Puma Biotechnology (PBYI) Interest Coverage Ratio Growth (1y) (2019 - 2026)
Puma Biotechnology (PBYI) Interest Coverage Ratio Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Puma Biotechnology |
384.39 Mn |
282.84 Mn |
34.39 Mn |
-386.15% |
| Date | Value |
|---|
| Mar 31, 2026 |
-386.15% |
| Dec 31, 2025 |
199.79% |
| Sep 30, 2025 |
-9.73% |
| Jun 30, 2025 |
659.02% |
| Mar 31, 2025 |
367.38% |
| Dec 31, 2024 |
15.57% |
| Sep 30, 2024 |
177.01% |
| Jun 30, 2024 |
-143.92% |
| Mar 31, 2024 |
-151.93% |
| Dec 31, 2023 |
44.44% |
| Sep 30, 2023 |
216.64% |
| Jun 30, 2023 |
-67.03% |
| Mar 31, 2023 |
570.01% |
| Dec 31, 2022 |
1,750.57% |
| Sep 30, 2022 |
128.30% |
| Jun 30, 2022 |
194.39% |
| Mar 31, 2022 |
-104.80% |
| Dec 31, 2021 |
94.08% |
| Sep 30, 2021 |
14.22% |
| Jun 30, 2021 |
-350.96% |
